These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 8733283

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA, Jones RN, Leeds JA, Denys G, Sader HS, Fritsche TR.
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
    Malmborg AS, Ahlén S.
    Chemotherapy; 1993 Jul; 39(1):32-5. PubMed ID: 8383030
    [Abstract] [Full Text] [Related]

  • 10. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL, Yang QW, Xu YC, Wang H, Xie XL, Chen MJ, Zhang XZ, Liu Y, Ye HF, Sun ZY, Duan Q, Ni YX, Yu YS, Zhao WS, He L, Wang J, Ji P, Liu PP, Zhang LX.
    Zhonghua Yi Xue Za Zhi; 2009 Nov 17; 89(42):2983-7. PubMed ID: 20137709
    [Abstract] [Full Text] [Related]

  • 11. In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens.
    Baquero F, Cantón R.
    J Antimicrob Chemother; 1996 May 17; 37 Suppl A():1-18. PubMed ID: 8737121
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
    Louie A, Baltch AL, Ritz WJ, Smith RP.
    Chemotherapy; 1991 May 17; 37(4):275-82. PubMed ID: 1665123
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H, Liu YL, Chen MJ, Xu YC, Sun HL, Yang QW, Hu YJ, Cao B, Chu YZ, Liu Y, Zhang R, Yu YS, Sun ZY, Zhuo C, Ni YX, Hu BJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb 17; 35(2):113-9. PubMed ID: 22455967
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan 17; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan 17; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 19. [In vitro antibacterial activity of a new fluoroquinolone, sparfloxacin, against nosocomial bacteria, and concordance curve].
    Soussy CJ, Cluzel M, Derlot E, Exmelin L, Kitzis MD, Dabernat H, Le Noc P, Muller-Serieys C, Reverdy ME, Scheftel JM, Thabaut A.
    Pathol Biol (Paris); 1996 Apr 17; 44(4):241-8. PubMed ID: 8763585
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo evaluation of BMY 45243, a new 5-amino-naphthyridone derivative.
    Bouzard D, Di Cesare P, Hoffmann P, Fung-Tomc J, Kessler R.
    Drugs Exp Clin Res; 1992 Apr 17; 18(7):291-4. PubMed ID: 1338310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.